Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 21521 - 21540 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX05) brentuximab vedotin | Adcetris 50 mg powder for injection, 1 vial | Powder for I.V. infusion 50 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
| Australia | (L01FX07) blinatumomab | Blincyto (1 x Blincyto vial, 1 x Blincyto IV Stabiliser vial), 1 pack | Powder for I.V. infusion 38.5 micrograms, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenAustraliaPtyLimited |
Pages
